Sweden · Delayed Price · Currency is SEK Nanologica AB Statistics
Total Valuation
Nanologica AB has a market cap or net worth of SEK 189.37 million. The enterprise value is 269.19 million.
| Market Cap | 189.37M |
| Enterprise Value | 269.19M |
Important Dates
The next confirmed earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nanologica AB has 328.77 million shares outstanding. The number of shares has increased by 57.24% in one year.
| Current Share Class | 328.77M |
| Shares Outstanding | 328.77M |
| Shares Change (YoY) | +57.24% |
| Shares Change (QoQ) | +2.56% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | 3.74% |
| Float | 244.61M |
Valuation Ratios
The trailing PE ratio is 2.22.
| PE Ratio | 2.22 |
| Forward PE | n/a |
| PS Ratio | 5.95 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 11.18 |
| EV / Sales | 8.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.22.
| Current Ratio | 1.15 |
| Quick Ratio | 0.53 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.26 |
| Interest Coverage | -11.08 |
Financial Efficiency
Return on equity (ROE) is 29.82% and return on invested capital (ROIC) is -18.36%.
| Return on Equity (ROE) | 29.82% |
| Return on Assets (ROA) | -15.67% |
| Return on Invested Capital (ROIC) | -18.36% |
| Return on Capital Employed (ROCE) | -33.99% |
| Weighted Average Cost of Capital (WACC) | 3.49% |
| Revenue Per Employee | 442,111 |
| Profits Per Employee | 334,278 |
| Employee Count | 72 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.03% in the last 52 weeks. The beta is -0.07, so Nanologica AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -49.03% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 50.08 |
| Average Volume (20 Days) | 6,199,326 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nanologica AB had revenue of SEK 31.83 million and earned 24.07 million in profits. Earnings per share was 0.26.
| Revenue | 31.83M |
| Gross Profit | 19.68M |
| Operating Income | -48.56M |
| Pretax Income | 24.07M |
| Net Income | 24.07M |
| EBITDA | -45.76M |
| EBIT | -48.56M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 39.25 million in cash and 119.07 million in debt, with a net cash position of -79.82 million or -0.24 per share.
| Cash & Cash Equivalents | 39.25M |
| Total Debt | 119.07M |
| Net Cash | -79.82M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 97.50M |
| Book Value Per Share | 0.81 |
| Working Capital | 17.95M |
Cash Flow
In the last 12 months, operating cash flow was -26.86 million and capital expenditures -1.08 million, giving a free cash flow of -27.94 million.
| Operating Cash Flow | -26.86M |
| Capital Expenditures | -1.08M |
| Depreciation & Amortization | 2.80M |
| Net Borrowing | 10.33M |
| Free Cash Flow | -27.94M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 61.82%, with operating and profit margins of -152.55% and 75.61%.
| Gross Margin | 61.82% |
| Operating Margin | -152.55% |
| Pretax Margin | 75.61% |
| Profit Margin | 75.61% |
| EBITDA Margin | -143.76% |
| EBIT Margin | -152.55% |
| FCF Margin | n/a |
Dividends & Yields
Nanologica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.24% |
| Shareholder Yield | -57.24% |
| Earnings Yield | 12.71% |
| FCF Yield | -14.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nanologica AB has an Altman Z-Score of -1.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.98 |
| Piotroski F-Score | 3 |